266 related articles for article (PubMed ID: 34149737)
1. Inhibition of Exosome Release Sensitizes U937 Cells to PEGylated Liposomal Doxorubicin.
Hekmatirad S; Moloudizargari M; Moghadamnia AA; Kazemi S; Mohammadnia-Afrouzi M; Baeeri M; Moradkhani F; Asghari MH
Front Immunol; 2021; 12():692654. PubMed ID: 34149737
[TBL] [Abstract][Full Text] [Related]
2. Palladium Nanoparticle-Induced Oxidative Stress, Endoplasmic Reticulum Stress, Apoptosis, and Immunomodulation Enhance the Biogenesis and Release of Exosome in Human Leukemia Monocytic Cells (THP-1).
Gurunathan S; Kang MH; Jeyaraj M; Kim JH
Int J Nanomedicine; 2021; 16():2849-2877. PubMed ID: 33883895
[TBL] [Abstract][Full Text] [Related]
3. Guggulsterone and bexarotene induce secretion of exosome-associated breast cancer resistance protein and reduce doxorubicin resistance in MDA-MB-231 cells.
Kong JN; He Q; Wang G; Dasgupta S; Dinkins MB; Zhu G; Kim A; Spassieva S; Bieberich E
Int J Cancer; 2015 Oct; 137(7):1610-20. PubMed ID: 25833198
[TBL] [Abstract][Full Text] [Related]
4. Voruciclib, a Potent CDK4/6 Inhibitor, Antagonizes ABCB1 and ABCG2-Mediated Multi-Drug Resistance in Cancer Cells.
Gupta P; Zhang YK; Zhang XY; Wang YJ; Lu KW; Hall T; Peng R; Yang DH; Xie N; Chen ZS
Cell Physiol Biochem; 2018; 45(4):1515-1528. PubMed ID: 29486476
[TBL] [Abstract][Full Text] [Related]
5. Pegylated liposomal formulation of doxorubicin overcomes drug resistance in a genetically engineered mouse model of breast cancer.
Füredi A; Szebényi K; Tóth S; Cserepes M; Hámori L; Nagy V; Karai E; Vajdovich P; Imre T; Szabó P; Szüts D; Tóvári J; Szakács G
J Control Release; 2017 Sep; 261():287-296. PubMed ID: 28700899
[TBL] [Abstract][Full Text] [Related]
6. Platinum Nanoparticles Enhance Exosome Release in Human Lung Epithelial Adenocarcinoma Cancer Cells (A549): Oxidative Stress and the Ceramide Pathway are Key Players.
Gurunathan S; Kang MH; Jeyaraj M; Kim JH
Int J Nanomedicine; 2021; 16():515-538. PubMed ID: 33519199
[TBL] [Abstract][Full Text] [Related]
7. Adipose tissue browning in cancer-associated cachexia can be attenuated by inhibition of exosome generation.
Hu W; Ru Z; Xiao W; Xiong Z; Wang C; Yuan C; Zhang X; Yang H
Biochem Biophys Res Commun; 2018 Nov; 506(1):122-129. PubMed ID: 30340833
[TBL] [Abstract][Full Text] [Related]
8. Exosomes derived from Taxol-resistant nasopharyngeal carcinoma (NPC) cells transferred DDX53 to NPC cells and promoted cancer resistance to Taxol.
Yuan F; Zhou ZF
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):127-138. PubMed ID: 33506900
[TBL] [Abstract][Full Text] [Related]
9. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
[TBL] [Abstract][Full Text] [Related]
10. Nuclear Trapping through Inhibition of Exosomal Export by Indomethacin Increases Cytostatic Efficacy of Doxorubicin and Pixantrone.
Koch R; Aung T; Vogel D; Chapuy B; Wenzel D; Becker S; Sinzig U; Venkataramani V; von Mach T; Jacob R; Truemper L; Wulf GG
Clin Cancer Res; 2016 Jan; 22(2):395-404. PubMed ID: 26369630
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin Expands in Vivo Secretion of Circulating Exosome in Mice.
Emam SE; Ando H; Abu Lila AS; Kobayashi S; Shimizu T; Okuhira K; Ishima Y; Ishida T
Biol Pharm Bull; 2018; 41(7):1078-1083. PubMed ID: 29962402
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of exosome release by ketotifen enhances sensitivity of cancer cells to doxorubicin.
Khan FM; Saleh E; Alawadhi H; Harati R; Zimmermann WH; El-Awady R
Cancer Biol Ther; 2018 Jan; 19(1):25-33. PubMed ID: 29244610
[TBL] [Abstract][Full Text] [Related]
13. Blockade of exosome generation by GW4869 inhibits the education of M2 macrophages in prostate cancer.
Peng Y; Zhao M; Hu Y; Guo H; Zhang Y; Huang Y; Zhao L; Chai Y; Wang Z
BMC Immunol; 2022 Aug; 23(1):37. PubMed ID: 35941539
[TBL] [Abstract][Full Text] [Related]
14. Gefitinib inhibition of drug resistance to doxorubicin by inactivating ABCG2 in thyroid cancer cell lines.
Lopez JP; Wang-Rodriguez J; Chang C; Chen JS; Pardo FS; Aguilera J; Ongkeko WM
Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1022-7. PubMed ID: 17938326
[TBL] [Abstract][Full Text] [Related]
15. Drug-resistant endothelial cells facilitate progression, EMT and chemoresistance in nasopharyngeal carcinoma via exosomes.
Huang L; Hu C; Chao H; Zhang Y; Li Y; Hou J; Xu Z; Lu H; Li H; Chen H
Cell Signal; 2019 Nov; 63():109385. PubMed ID: 31394194
[TBL] [Abstract][Full Text] [Related]
16. Exosomes Derived from Human Pulmonary Artery Endothelial Cells Shift the Balance between Proliferation and Apoptosis of Smooth Muscle Cells.
Zhao L; Luo H; Li X; Li T; He J; Qi Q; Liu Y; Yu Z
Cardiology; 2017; 137(1):43-53. PubMed ID: 28068653
[TBL] [Abstract][Full Text] [Related]
17. Stimulating the Release of Exosomes Increases the Intercellular Transfer of Prions.
Guo BB; Bellingham SA; Hill AF
J Biol Chem; 2016 Mar; 291(10):5128-37. PubMed ID: 26769968
[TBL] [Abstract][Full Text] [Related]
18. Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center.
Khallaf SM; Roshdy J; Ibrahim A
J Egypt Natl Canc Inst; 2020 Apr; 32(1):20. PubMed ID: 32372114
[TBL] [Abstract][Full Text] [Related]
19. Treatment of acquired drug resistance in multiple myeloma by combination therapy with XPO1 and topoisomerase II inhibitors.
Turner JG; Dawson JL; Grant S; Shain KH; Dalton WS; Dai Y; Meads M; Baz R; Kauffman M; Shacham S; Sullivan DM
J Hematol Oncol; 2016 Aug; 9(1):73. PubMed ID: 27557643
[TBL] [Abstract][Full Text] [Related]
20. Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells.
Wang X; Huang W; Liu G; Cai W; Millard RW; Wang Y; Chang J; Peng T; Fan GC
J Mol Cell Cardiol; 2014 Sep; 74():139-50. PubMed ID: 24825548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
